Loyal
San Francisco · Founded 2019
About Loyal
Loyal is a biotechnology company developing medicines to extend dog lifespan. By developing drugs with the potential to slow the aging process, they aim to delay or prevent age-related diseases like cancer and dementia. By quantifying and regulating the processes of aging, the company aims to slow the emergence and mitigate the intensity of age-related ailments, thereby facilitating extended periods of improved health for both species.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $237.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Feb 2026)
- Website: https://loyalfordogs.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Pet, Veterinary
Social Profiles
Canonical: https://fsome.com/organization/loyal-23205 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.